Group One Trading
ONC

Group One Trading’s BeOne Medicines Ltd ONC Stock Holding History

Group One Trading’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-300
Closed -$72.6K – 9319
2025
Q2 		$72.6K Hold
300
– – ﹤0.01% 5254
2025
Q1 		$81.7K Buy
300
+200
+200% +$46.8K ﹤0.01% 4761
2024
Q4 		$18.5K Hold
100
– – ﹤0.01% 5748
2024
Q3 		$22.5K Hold
100
– – ﹤0.01% 5169
2024
Q2 		$14.3K Sell
100
-100
-50% -$15.4K ﹤0.01% 5437
2024
Q1 		$31.3K Buy
+200
New +$32.2K ﹤0.01% 5083
2023
Q4 		– Sell
-100
Closed -$18K – 8333
2023
Q3 		$18K Sell
100
-9,500
-99% -$1.88M ﹤0.01% 5959
2023
Q2 		$1.71M Buy
9,600
+9,500
+9,500% +$2.19M 0.01% 1861
2023
Q1 		$21.6K Sell
100
-900
-90% -$216K ﹤0.01% 5446
2022
Q4 		$220K Buy
1,000
+900
+900% +$165K ﹤0.01% 3787
2022
Q3 		$13K Buy
+100
New +$17.2K ﹤0.01% 6355
2022
Q2 		– Sell
-5,000
Closed -$943K – 8668
2022
Q1 		$943K Buy
+5,000
New +$1.06M ﹤0.01% 3139
2021
Q4 		– Sell
-2,200
Closed -$799K – 8953
2021
Q3 		$799K Buy
+2,200
New +$719K ﹤0.01% 3658
2021
Q2 		– Sell
-6,800
Closed -$2.37M – 8657
2021
Q1 		$2.37M Buy
6,800
+6,700
+6,700% +$2.22M ﹤0.01% 2278
2020
Q4 		$26K Sell
100
-11,000
-99% -$3.03M ﹤0.01% 5379
2020
Q3 		$3.18M Buy
11,100
+11,000
+11,000% +$2.59M 0.01% 1230
2020
Q2 		$19K Hold
100
– – ﹤0.01% 4859
2020
Q1 		$12K Sell
100
-400
-80% -$62.6K ﹤0.01% 4500
2019
Q4 		$83K Sell
500
-12,500
-96% -$2.08M ﹤0.01% 3756
2019
Q3 		$1.59M Buy
13,000
+7,000
+117% +$930K 0.01% 1383
2019
Q2 		$744K Buy
+6,000
New +$762K 0.01% 1804
2018
Q3 		– Sell
-9,700
Closed -$1.49M – 5679
2018
Q2 		$1.49M Sell
9,700
-8,200
-46% -$1.46M 0.01% 1341
2018
Q1 		$3.01M Buy
+17,900
New +$2.42M 0.03% 734

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Group One Trading's ONC Position: Q1 2026 in Review

Group One Trading sold out of BeOne Medicines Ltd (ONC) in Q1 2026, closing a stake of 200 shares — an estimated $60.8K sold.

Group One Trading first reported a position in ONC in Q2 2018 and held it in 16 quarters. The position peaked at $1.42M in Q4 2020. 281 funds tracked by Wall St. Rank hold ONC as of Q1 2026.

  • Group One Trading reported no remaining BeOne Medicines Ltd position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 200 BeOne Medicines Ltd shares in Q1 2026, an estimated $60.8K.
  • Group One Trading first reported a position in BeOne Medicines Ltd in Q2 2018 and held it in 16 quarters.
  • Group One Trading's BeOne Medicines Ltd position peaked at $1.42M in Q4 2020.
  • 281 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.